Plain-English translation of NCT07531199 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding a special releasable suture inside the Preserflo device during glaucoma surgery can safely lower eye pressure while preventing a common complication called hypotony (eye pressure that becomes too low). The Preserflo is a tiny drainage device already approved in France that helps fluid drain from the eye to reduce pressure. This study will compare the standard Preserflo surgery to the same surgery with the added suture technique.
While the Preserflo device is very effective at lowering eye pressure, it can sometimes cause the pressure to drop too low after surgery, which can damage vision. Researchers want to know if adding a releasable suture can prevent this complication while keeping the treatment just as effective.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive glaucoma surgery using the Preserflo device. You will be randomly assigned to either the standard surgical technique or the modified technique with the releasable suture. After surgery, you will have follow-up visits where your eye pressure, vision, and healing will be monitored to see if the new technique reduces the risk of low eye pressure while maintaining effectiveness.
AI-generated summary from trial data · Oct 6, 2026 · Not medical advice
France